J Fedida1,2,3, T Strisciuglio4,5, M Sohal6, M Wolf4, K Van Beeumen4, A Neyrinck4, P Taghji4, C Lepiece7, A Almorad4, Y Vandekerckhove4, R Tavernier4, M Duytschaever4, S Knecht4. 1. Cardiology, St-Jan Hospital, Bruges, Belgium. fedidajoel@gmail.com. 2. Hopital Pitié-Salpêtrière, Paris 6 Sorbonne Université, Institut de Cardiologie, Paris, France. fedidajoel@gmail.com. 3. Département de Cardiologie, AP-HP, Hôpital Pitié-Salpêtrière, 47-83 bld de l'Hôpital, 75013, Paris, France. fedidajoel@gmail.com. 4. Cardiology, St-Jan Hospital, Bruges, Belgium. 5. University of Naples Federico II, Naples, Italy. 6. Cardiology, George's Healthcare NHS Trust, London, UK. 7. Hopital de Jolimont, La Louvière, Belgium.
Abstract
PURPOSE: Catheter ablation is an effective treatment for premature ventricular complexes (PVCs). Activation mapping is accurate but requires PVCs at the time of the ablation. Pace-mapping correlation (PMC) is a supplemental tool recently developed as an integrated module for an electro-anatomical mapping platform. Our study sought to investigate whether pace-mapping technology provides similar ablation results in patients with low versus high idiopathic PVC burden at the time of ablation and the relationship between sites with the highest PMC and the earliest local activation time (LAT). METHODS: A total of 59 consecutive patients undergoing catheter ablation for idiopathic PVCs were enrolled. Twelve out of 59 patients (20%) were classified in the low PVC burden group (defined as < 2 PVCs/min) and 47/59 (80%) in the high PVC burden group. RESULTS: The most common origin of PVCs was the right ventricular outflow tract (RVOT) followed by aortic cusps, coronary sinus, parahisian region, and aorto-mitral continuity. Procedural and 1-month success rate were 95 and 87% respectively. PVC burden at the time of ablation did not influence the success rate. The median distance between the earliest LAT points and the highest PMC points was 6.4 (4.9-10.6) mm. CONCLUSIONS: Pace-mapping correlation is useful and accurate in localizing the origin of idiopathic PVCs irrespective of the initial PVC burden. It provides optimal ablation results when combined with LAT. Success rate at mid-term follow-up is higher when the origin of PVCs is located in the RVOT as compared to other locations.
PURPOSE: Catheter ablation is an effective treatment for premature ventricular complexes (PVCs). Activation mapping is accurate but requires PVCs at the time of the ablation. Pace-mapping correlation (PMC) is a supplemental tool recently developed as an integrated module for an electro-anatomical mapping platform. Our study sought to investigate whether pace-mapping technology provides similar ablation results in patients with low versus high idiopathic PVC burden at the time of ablation and the relationship between sites with the highest PMC and the earliest local activation time (LAT). METHODS: A total of 59 consecutive patients undergoing catheter ablation for idiopathic PVCs were enrolled. Twelve out of 59 patients (20%) were classified in the low PVC burden group (defined as < 2 PVCs/min) and 47/59 (80%) in the high PVC burden group. RESULTS: The most common origin of PVCs was the right ventricular outflow tract (RVOT) followed by aortic cusps, coronary sinus, parahisian region, and aorto-mitral continuity. Procedural and 1-month success rate were 95 and 87% respectively. PVC burden at the time of ablation did not influence the success rate. The median distance between the earliest LAT points and the highest PMC points was 6.4 (4.9-10.6) mm. CONCLUSIONS: Pace-mapping correlation is useful and accurate in localizing the origin of idiopathic PVCs irrespective of the initial PVC burden. It provides optimal ablation results when combined with LAT. Success rate at mid-term follow-up is higher when the origin of PVCs is located in the RVOT as compared to other locations.
Entities:
Keywords:
Catheter ablation; Local activation time; Pace mapping; Premature ventricular complexes
Authors: Miki Yokokawa; Hyungjin Myra Kim; Eric Good; Aman Chugh; Frank Pelosi; Craig Alguire; William Armstrong; Thomas Crawford; Krit Jongnarangsin; Hakan Oral; Fred Morady; Frank Bogun Journal: Heart Rhythm Date: 2011-08-17 Impact factor: 6.343
Authors: Edward P Gerstenfeld; Sanjay Dixit; David J Callans; Yadavendra Rajawat; Robert Rho; Francis E Marchlinski Journal: J Am Coll Cardiol Date: 2003-06-04 Impact factor: 24.094
Authors: Aravinda Thiagalingam; Andre D'Avila; Lori Foley; J Luis Guerrero; Hendrik Lambert; Giovanni Leo; Jeremy N Ruskin; Vivek Y Reddy Journal: J Cardiovasc Electrophysiol Date: 2010-02-01
Authors: Silvia G Priori; Carina Blomström-Lundqvist; Andrea Mazzanti; Nico Blom; Martin Borggrefe; John Camm; Perry Mark Elliott; Donna Fitzsimons; Robert Hatala; Gerhard Hindricks; Paulus Kirchhof; Keld Kjeldsen; Karl-Heinz Kuck; Antonio Hernandez-Madrid; Nikolaos Nikolaou; Tone M Norekvål; Christian Spaulding; Dirk J Van Veldhuisen Journal: Eur Heart J Date: 2015-08-29 Impact factor: 29.983
Authors: Jean-Francois Sarrazin; Troy Labounty; Michael Kuhne; Thomas Crawford; William F Armstrong; Benoit Desjardins; Eric Good; Krit Jongnarangsin; Aman Chugh; Hakan Oral; Frank Pelosi; Fred Morady; Frank Bogun Journal: Heart Rhythm Date: 2009-08-05 Impact factor: 6.343